Health

No Image

As Artificial Intelligence Moves Into Medicine, The Human Touch Could Be A Casualty

Will computers alienate us from the healing touch?

Credit: Chris Nickels for NPR

When Kim Hilliard shows up at the clinic at the New Orleans University Medical Center, she’s not there simply for an eye exam. The human touches she gets along the way help her navigate her complicated medical conditions.

In addition to diabetes, the 56-year-old has high blood pressure. She has also had back surgery and has undergone bariatric surgery to help her control her weight.

Hilliard is also at risk of blindness, which can result from a condition called diabetic retinopathy. And on this day in February, her vision will be evaluated by a new practitioner: a piece of software.

Automation like this is starting to infiltrate medical care. Depending on how it’s deployed, it could help reduce medical errors and potentially reduce the cost of care.

It could also create a gulf between health caregivers and people of more modest means.

“My fear is we will end up with what I’ve been calling a ‘health care apartheid,’ ” says Sonoo Thadaney Israni, at the Stanford University medical school. “If we create algorithmic care and ‘kiosk’ it in some fashion — focusing on efficiency and throughput — the people who will end up having access and using it will be the ones who already lack privileges of various kinds.”

We are far from that dystopian world at the moment, but are we moving in that direction? That possibility concerns her.

Hilliard’s experience at the clinic underscores the importance of human contact. She’s here for an annual eye exam to look for signs of blindness that can arise in people with diabetes.

“I got the full diabetes when I made 40,” she says. It’s a challenge for her to stay on top of all her medical conditions. “I go to so many doctor’s appointments I get tired,” she says.

The software to identify early signs of diabetic retinopathy, called IDxDR, can do that job without expert intervention, but skilled medical personnel at this clinic are, for the moment at least, still playing a hands-on role.

After Hilliard finishes the exam, nurse practitioner Chevelle Parker shows her images of her eye.

“If we zoom in here, we can see some little fat deposits here, OK?” Parker says. Hilliard leans in and studies the image of her retina.

“That can be from the foods you’re eating,” Parker says. “Think of some of the fatty foods you’re eating — sausage, bacon.”

Hilliard says she stopped eating those foods last fall, after her gastric bypass surgery.

“Well, when you were eating those, the deposits were being placed on the eye,” Parker explains. “That’s why we talk to you about your diet. And now that you know you can’t have that, this is the reason why, OK?”

Parker goes on to reinforce the dietary recommendations for diabetes. Hilliard should eat breakfast within an hour or so of waking up, and she should be sure to have some protein, rather than carbohydrates, at the end of the day.

Hilliard gratefully accepts the advice, along with a referral to an ophthalmologist, who will need to get a closer look at the signs of damage in her eye.

“I do what I can do to keep from going blind,” Hilliard says. “So whatever they tell me to do that’s what I do. At least I try.”

Hilliard’s experience is a stark reminder that health care is more than a simple transaction. Six in 10 adults in the United States have a chronic disease, and 4 in 10 have two or more, according to the Centers for Disease Control and Prevention.

This is the real world, in which computer algorithms are starting to take off in medicine.

“I think for too long we’ve had this assumption that any new technology is good, more is better,” says Abraham Verghese, a physician who works in partnership with Thadaney at a Stanford center that focuses on the human aspects of medical care.

“New is not always better,” he says as the three of us sit together in their office.

Medical care, like so much of our society, creates haves and have-nots, Thadaney says. “We need to make sure that technology doesn’t further exacerbate the issues of equity and inclusion.”

“Just to carry that thought forward,” Verghese says, “AI algorithms we already know are causing inequities in bail bonding, inequities in real estate,” as well as in policing. Unconscious racism and other biases get baked in, without the developers even being aware of it. “That same kind of algorithmic approach can easily infect medicine and probably does,” Verghese says.

These technologies are driven by companies interested in turning a profit, and that doesn’t necessarily lead to better care. In fact, the cost-savings these technologies promise could be the result of reducing the time an individual spends face-to-face with a doctor or nurse.

“One thing that I think is unchanged since antiquity is that when you’re seriously ill, you feel bad,” says Verghese. “And amongst all the other things you need, you also want someone to care for you — not just your family member but someone with the scientific knowledge to also express care.”

Thadaney says a member of her household recently brought that point home. He had been injured in a bicycle accident. Treatment involved a complicated trek through two hospitals and a rehabilitation facility. Thadaney was able to advocate for him. “I was able to call friends who are physicians,” she says. “I was able to, you know, call into the leadership of those organizations and request for something different.”

That intervention alone provided an edge to her family member, but she says what really helped him was a visit with Verghese. The doctor “didn’t tell him anything different than he already knew,” she says, but he provided comfort and reassurance, “and I think it hastened his healing.”

Verghese says he was recently reading Walt Whitman’s accounts of his time caring for the wounded in Civil War medical tents on the Mall in Washington, D.C.

“He did what those young men most needed,” Verghese says. “They were so far from home. They needed someone to read to them, to hold their hands and to write letters for them and take care of their every task. And it was the most elemental kind of care. Nothing’s changed. You know we’re still the same human beings.”

Verghese is hopeful that technology, such as artificial intelligence, can improve medical care, but only if it isn’t done at the expense of human contact. AI has the potential to free up clinicians to spend more time with their patients, depending on how it ends up being deployed. In principle, AI could also help the most challenging tasks.

“We don’t need another image recognition [system],” he says. “They’re all nice great and very tidy.”

But where the technology can do the most good is to help sort through the clues gathered during medical treatment. “Medicine is messy,” he says. “Help us out.”

Some of the nuts-and-bolts improvements that AI can bring have their place, Thadaney says. “Yes, the patient wants you to make sure that you have efficiencies in your system so they don’t get 19 bills with the same stupid thing.”

But patients also want to get better. To help accomplish that, doctors and nurses can’t simply be adjuncts to machines. Her mantra to the young doctors she advises is this: “In the end, be present. That matters a great deal.”

In March, Stanford inaugurated a new institute to focus on the human dimensions of artificial intelligence.

Dr. Russ Altman, a professor of bioengineering and genetics at Stanford and an associate director of the new institute, says it is important to have best practices in place as technology and medicine commingle. “It’s unfair and unrealistic to expect that technologists to be experts at all this.”

He shares the concerns of Verghese and Thadaney that machines could degrade the human relationship at the core of medicine.

“Medicine is a combination of art and science,” which will be augmented by AI, Altman says. “But the act of laying your hands on a patient, showing that you really care about what is there, what their problem is [and] assuring them that you’re going to be with them through an odyssey — that might take a while,” he says. “That is very difficult to imagine being replaced by computers.”

You can contact NPR Science Correspondent Richard Harris at rharris@npr.org.

Let’s block ads! (Why?)


No Image

Measles Cases In The U.S. Reach Highest Count In 25 Years

Federal health officials released the latest national measles count Monday. Measles has been reported in 22 states.



AILSA CHANG, HOST:

Federal health officials are increasingly alarmed about the spread of measles around the country. They’re urging parents to vaccinate their kids in the face of record-setting outbreaks. NPR health correspondent Rob Stein has the details.

ROB STEIN, BYLINE: At least 704 cases of measles have now been reported in 22 states. And Health and Human Services Secretary Alex Azar says that’s the most measles in the United States in 25 years.

(SOUNDBITE OF ARCHIVED RECORDING)

ALEX AZAR: We are very concerned about the recent troubling rise in cases of measles, which was declared eliminated from our country in 2000. Vaccine-preventable diseases belong in the history books, not our emergency rooms.

STEIN: Most of the measles cases are from outbreaks in Washington state and New York. The Washington outbreak has subsided. But measles is still spreading in two outbreaks in New York, one in Brooklyn and the other about an hour north of Manhattan. Those are the largest and longest measles outbreaks since the disease was eliminated in 2000. And hundreds of college students have been quarantined because of measles in California. Why is measles back like this?

(SOUNDBITE OF ARCHIVED RECORDING)

AZAR: While most parents are getting their children vaccinated, the vast majority of these cases involve children who have not been vaccinated.

STEIN: And have gotten exposed to measles by people who caught the virus in countries like Ukraine, Israel and the Philippines, where big outbreaks are underway and have brought the highly contagious measles virus into communities with lots of unvaccinated kids. Here’s CDC Director Robert Redfield.

ROBERT REDFIELD: Measles is incredibly contagious. A person who has measles can make other people sick four days before they get a rash. If an infected person enters a room of 10 unvaccinated people, nine of them will get measles.

STEIN: Most will recover. But there’s no way to treat measles, and it can cause severe complications. So far this year, about 3% of people with measles have ended up with pneumonia; 9% have been hospitalized. No one has died. But Health and Human Services Secretary Azar says that could happen.

(SOUNDBITE OF ARCHIVED RECORDING)

AZAR: Most of us have never seen the deadly consequences that vaccine-preventable diseases can have on a child, family or a community, and that’s the way we want to keep it.

STEIN: So federal, state and local health officials are racing to counter misinformation that’s apparently being targeted at some communities about the measles vaccine. Nancy Messonnier directs the CDC’s National Center for Immunization and Respiratory Diseases. She says the measles vaccine is highly effective and safe.

NANCY MESSONNIER: We have definitely seen misinformation and myths about vaccines being sent to communities susceptible to that misinformation. And these vulnerable communities are the communities in which we’re seeing these outbreaks right now.

STEIN: Like Orthodox Jewish communities in New York. Messonnier worries that if the outbreaks aren’t brought under control soon, it could have longterm implications for the country.

MESSONNIER: The longer these outbreaks continue, the greater the chance that measles will again get a foothold in the United States.

STEIN: So officials are trying to counter the misinformation, and some lawmakers are calling for the elimination of rules that allow parents to opt out of getting their kids vaccinated. Rob Stein, NPR News.

(SOUNDBITE OF NICK BOX’S “THOUGHTS”)

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)


No Image

Melinda Gates On Marriage, Parenting, And Why She Made Bill Drive The Kids To School

Melinda Gates at a panel discussion in New York City in February. She is the author of a new book, “The Moment of Lift: How Empowering Women Changes the World.”

John Lamparski/Getty Images


hide caption

toggle caption

John Lamparski/Getty Images

Melinda Gates, the co-founder of the Bill & Melinda Gates Foundation, has written a new book, The Moment of Lift: How Empowering Women Changes The World.

Published this week, the book calls on readers to support women everywhere as a means to lift up society. She pulls from her lessons learned through the inspiring women she’s met on her travels with the Gates Foundation, which funds projects to reduce poverty and improve global health in the developing world (and is a funder of NPR and this blog).

But Gates also addresses gender equality in the United States — using her own personal story as an example. Opening up about her marriage to Bill, she talks about some of the challenges they faced in sharing the burden of parenting. And she reveals her struggle to balance her role as a mom of three, her career as a tech pioneer and philanthropist, and the public life of being married to one of the world’s richest men.

This interview has been edited for length and clarity.

In the opening pages, you talk about how you learned to renegotiate the terms of your marriage — once you stopped working at Microsoft — to focus on raising the kids. Why did you think it was important to share this?

In society there are so many issues that women face and we don’t even realize what we’re up against. So I chose to write my story so that hopefully people and women and men could relate to me and understand that yes, these issues exist in every single marriage.

I wanted to have both a family and I knew I wanted to go back to work. And so [Bill and I] had some negotiation to do. We said, “OK who’s going to do what in our home? And how were we going to split up those roles?”

There’s a cute story in your book that speaks to that. You talk about how you asked your husband to start sharing the responsibility of dropping the kids off at school. After a couple of weeks, you said you noticed that a lot more men were doing the drop offs. And you asked one of your friends about and she said that when we saw Bill driving, we went home and said to our husbands: Bill Gates is driving his child to school. You can too. Why did you choose to highlight this story?

The reason I wrote that specific story [is that it’s] an example of this unpaid labor that women do all over the world. In the U.S., women do 90 minutes more of unpaid labor at home than their husbands do. That’s things like doing the dishes, carpooling, doing the laundry.

Unless we look at that and redistribute it, we’re not going to let women do some of the more productive things they want to do.

The Gates Foundation is primarily focused on solving challenges in the developing world. But what are you doing to address issues a big topic you discuss in your book, women’s equality in the United States?

When I would be flying home from various countries in Africa or Bangladesh, I’d be saying to myself: Why aren’t women more empowered in those countries? And it wasn’t until I turned the question back on myself and I said, “How far are we here in the United States?”

That is why I set up a separate office from the foundation, Pivotal Ventures, to start tackling these inequities for women and the barriers in the United States.

We are the only industrialized nation in the world that does not have paid family medical leave. So I would say to young women and men in this country who are in their 20s and 30s: Gender roles change when you start to have children. You need to question them, and you also need to say what should we do, public policy-wise, to support women.

A lot of the book is focused on your story, but you also talk about women around the world who are facing extreme poverty and violence in their homes. The subtitle of your book is “How Empowering Women Changes The World.” What’s the short answer?

I believe that in empowering women, you do empower everybody else because you lift up a woman. She lifts up the rest of her family and her community and her society and her economy. And so this is absolutely about lifting up women and lifting up people of color.

You quote a friend several times in this book who was very skeptical of the ability of American billionaires to make a meaningful difference in the lives of those facing extreme poverty. Is this something you think as a society we should be talking about?

Bill and I are on record saying we believe high-income people should pay more than a middle-income family [who would] then pay more than a low-income family. It’s time to revisit some of the tax policies in our society.

But make no mistake. Living in a capitalistic structure is a fabulous place to live. I meet so many families around the world who want to live in the United States and have the system we have. Warren Buffett, our co-trustees, my husband Bill — they could not have started the companies they have in Malawi or in Senegal or in Niger. We benefit from the structure we have in the United States. But we don’t have it all right. And it’s time to revisit the pieces that create some of these inequities.

How do you feel now that you’ve put your life all out there in the book?

At the moment, I feel really great. I am really comfortable at age 54 with who I am. And so I’m kind of like, take it or leave it.

Let’s block ads! (Why?)


No Image

Does Taking Time For Compassion Make Doctors Better At Their Jobs?

Studies show that when doctors practice compassion, patients fare better, and doctors experience less burnout.

Cavan Images/Getty Images/Cavan Images RF


hide caption

toggle caption

Cavan Images/Getty Images/Cavan Images RF

For most of his career, Dr. Stephen Trzeciak was not a big believer in the “touchy-feely” side of medicine. As a specialist in intensive care and chief of medicine at Cooper University Health Care in Camden, N.J., Trzeciak felt most at home in the hard sciences.

Then his new boss, Dr. Anthony Mazzarelli, came to him with a problem: Recent studies had shown an epidemic of burnout among health care providers. As co-president of Cooper, Mazzarelli was in charge of a major medical system and needed to find ways to improve patient care.

He had a mission for Trzeciak — he wanted him to find answers to this question: Can treating patients with medicine and compassion make a measurable difference on the wellbeing of both patients and doctors?

Trzeciak wasn’t convinced. Sure, compassion is good, Trzeciak thought, but he expected to review the existing science and report back the bad news that caring has no quantitative rationale. But Mazzarelli was his colleague and chief, so he dove in.

To find more stories about how to live well, sign up for the Life Kit newsletter. Life Kit is NPR’s family of podcasts for helping you get your life together. Every two weeks, we drop new episodes and publish a newsletter with helpful stories like this one.

After considering more than 1,000 scientific abstracts and 250 research papers, Trzeciak and Mazzarelli were surprised to find that the answer was, resoundingly, yes. When health care providers take the time to make human connections that help end suffering, patient outcomes improve and medical costs decrease. Among other benefits, compassion reduces pain, improves healing, lowers blood pressure and helps alleviate depression and anxiety.

In their new book, Compassionomics: The Revolutionary Scientific Evidence that Caring Makes a Difference, Trzeciak and Mazzarelli lay out research showing the benefits of compassion, and how it can be learned. One study they cite shows that when patients received a message of empathy, kindness and support that lasted just 40 seconds their anxiety was measurably reduced.

But compassion doesn’t just benefit its recipients, Trzeciak and Mazzarelli learned. Researchers at the Wharton School of the University of Pennsylvania found that when people spent time doing good for others (by writing an encouraging note to a gravely ill child), it actually changed their perception of time to make them feel they had more of it.

For doctors, this point is crucial. Fifty-six percent say they don’t have time to be empathetic.

“The evidence shows that when you invest time in other people, you actually feel that you have more time, or that you’re not so much in a hurry,” Trzeciak says. “So when 56 percent say they don’t have time in that survey, it’s probably all in their heads.”

The good news is, the same study that found doctors didn’t have time for empathy, also showed that a short training in the neuroscience of empathy made doctors interact with patients in ways patients rated as more empathetic.

Compassion also seems to prevent doctor burnout — a condition that affects almost half of U.S. physicians. Medical schools often warn students not to get too close to patients, because too much exposure to human suffering is likely to lead to exhaustion, Trzeciak says. But the opposite appears to be true: Evidence shows that connecting with patients makes physicians happier and more fulfilled.

“We’ve always heard that burnout crushes compassion. It’s probably more likely that those people with low compassion, those are the ones that are predisposed to burnout,” Trzeciak said. “That human connection — and specifically a compassionate connection — can actually build resilience and resistance to burnout.”

Trzeciak and Mazzarelli hope their evidenced-based arguments will spur medical schools to make compassion part of the curriculum.

For those outside the health care system, acting with compassion can be a kind of therapy as well, the authors say. They cite the phenomenon of the “helper’s high,” the good feeling that comes from helping others, and explain how giving to others benefits the givers’ brains and nervous systems.

“I can say this with confidence,” Trzeciak says. “Other-focused behavior is beneficial to your own mental health.”

For Trzeciak, the research had a personal effect. When he started into the project, he’d been

going through his own existential crisis, triggered by his son’s middle school homework assignment that asked, “What is the most pressing problem of our time?” While he believed his work to that point was meaningful, it was definitely not the most pressing problem of our time.

Along the way, he says, he realized he was feeling burned out after 20 years of practicing medicine. So, armed with data from his book research, he decided to test his own hypothesis.

“The recommended prescription is what I call ‘escapism’ — get away, detach, pull back, go on some nature hikes or whatever but I was not believing it,” Trzeciak explains in a TEDxPenn talk.

Instead, he says, he applied the techniques he’d been studying, including spending at least 40 seconds expressing compassion to patients. “I connected more, not less; cared more, not less; leaned in rather than pulled back. And that was when the fog of burnout began to lift.”

He prescribes the same for anyone, not just health care providers, suffering from mental or emotional exhaustion.

“Look around you and see those in need of compassion and give your 40 seconds of compassion,” he says. “See how it transforms your experience.”

Let’s block ads! (Why?)


No Image

County Jails Struggle With A New Role As America’s Prime Centers For Opioid Detox

In Massachusetts last July, several Franklin County Jail inmates were watched by a nurse and a corrections officer after receiving their daily doses of buprenorphine, a drug that helps control opioid cravings. By some estimates, at least half to two-thirds of today’s U.S. jail population has a substance use or dependence problem.

Elise Amendola/AP


hide caption

toggle caption

Elise Amendola/AP

Faced with a flood of addicted inmates and challenged by lawsuits, America’s county jails are struggling to adjust to an opioid health crisis that has turned many of the jails into their area’s largest drug treatment centers.

In an effort to get a handle on the problem, more jails are adding some form of medication-assisted treatment, or MAT, to help inmates safely detox from opioids and stay clean behind bars and after release.

But there are deep concerns about potential abuse of the treatment drugs, as well as worries about the efficacy and costs of programs that jails just weren’t designed or built for.

“It was never traditionally the function of jail to be a treatment provider, nor to be the primary provider of detoxification in the country — which is what they have become,” says Andrew Klein, the senior criminal justice research scientist with the company Advocates for Human Potential, which advises on jail and prison substance abuse treatment programs across the U.S. “So, with the opioid epidemic, jails are scrambling to catch up.”

A “critical situation”

The National Sheriffs’ Association estimates that at least half to two-thirds of today’s jail population has a drug abuse or dependence problem. Some counties say the number is even higher.

“We are in a critical situation,” says Peter Koutoujian, a leading voice on the issue and the sheriff of Middlesex County, Mass. — one of the states hardest hit by the opioid epidemic.

“We have to physically, medically detox about 40% of our population as they come in off the street,” he says, “and probably 80 to 90% of our population inside has some type of drug or alcohol dependence.”

Koutoujian, who is also vice president of the Major County Sheriffs of America, says how best to treat opioid-addicted inmates is among the most pressing issues facing jails today.

“We have not been able to get our hands around it because, quite honestly, society has not gotten its hand around either preventing [drug-addicted] people from coming into our institutions or supporting them once they get back outside,” he says.

“The fact is you shouldn’t have to come to jail to get good [treatment] programming,” says Koutoujian. “You should be able to get that in your own community so you don’t have to have your life disrupted by becoming incarcerated.”

An ever-growing number of jails — 85 percent of which are run by local sheriffs — are trying to expand the use of medication-assisted addiction treatment behind bars, including the use of buprenorphine and methadone, among other drugs.

“Dead addicts don’t recover”

Jails in states hardest hit by opioids — including Ohio, Kentucky, West Virginia, Rhode Island and Massachusetts — are moving fastest to expand this use of medicine, which is now widely considered the most effective method of treating opioid use disorder. The National Sheriffs’ Association recently put out a detailed best practices guide to jail-based medication-assisted treatment, in conjunction with the National Commission on Correctional Health Care.

“Dead addicts don’t recover. So this is our opportunity to engage this population,” says Carlos Morales the director of correctional health services for California’s San Mateo County, just south of San Francisco.

Morales is working to expand access to medications for an older model of drug treatment that has long relied on abstinence and a “cold turkey” approach.

“We know if you are an opiate user you come in here, you detox, and you go out — it’s a 40 percent chance of OD-ing,” Morales says. “And we have the potential to do something about it.”

Felipe Chavez, who’s doing time at the San Mateo jail for selling fentanyl, is taking part in the jail’s fledgling opioid treatment program. Chavez says opioids have ruled his life since he started using oxycodone pills at age 12, following an injury.

“I was smoking them,” Chavez says. “Then I went to heroin. Then heroin went to fentanyl.”

With his sleepy eyes and loose-fitting clothes, Chavez looks younger than his 23 years – a little like a teenager in baggy pajamas. But the bright hunter-orange of everything he’s wearing, down to the plastic Crocs, all signify he’s in the San Mateo County jail’s infirmary in Redwood City, Calif., where he gets his regular dose of methadone.

Still, Chavez is one of the lucky ones here. Because he was in a local methadone program before he got arrested — again — he has been allowed to keep using that synthetic opioid substitute in jail. Methadone and a couple other drugs help jailed opioid users like Chavez temper cravings and, in theory, stay off more powerful and destructive opioids.

“It’s all about if you want to get clean or not, you know,” Chavez says. “The methadone is just there to help, you know. I mean, you’ve got to dedicate to the methadone. Because you got to start somewhere.”

With the methadone treatment he says, “I just feel more normal — like a normal person.”

Jail as an “opportunity to intervene”

Doctors who treat people in jails say a challenge — and an opportunity — in expanding the use of methadone or another medical treatment is that it’s not clear, at first at least, how big a role opioid addiction is playing in an inmate’s troubles; their drug use is often intertwined with mental health problems.

“The opiate part of the problem is usually not part of the charging documents, so it’s hard to tell,” says Dr. Robert Spencer, San Mateo County’s correctional health medical director. Addiction, mental health and crime “are so intimately connected,” Spencer says. “It’s often a form of self-medication, an attempt by them to modify their symptoms. This gives us an opportunity to provide an intervention and a possible way forward.”

More research is needed to confirm the long-term benefits of treating addiction in jail, addiction specialists say. But, so far, studies have shown that medication-assisted treatment works well in reducing fatal overdoses, relapse and in reducing the spread of infectious diseases, such as HIV.

Still, this kind of medication-based approach is relatively new in San Mateo — as it is for many jails across the country. For nearly a quarter century, San Mateo’s flagship addiction treatment program has been an abstinence-based approach called Choices. So far, only a dozen or so of the jails’ roughly 1,000 inmates are undergoing some sort of medication-assisted treatment.

Correctional health director Morales wants to expand those numbers. But he has lingering worries about costs, effectiveness and safety. He says inmates can hoard — and then sell, trade or abuse — some of the opioid treatment drugs, which are among the most top contraband items in jails today.

In addition, prison reforms in California to reduce overcrowding and reclassify some sentences has resulted in county jails housing more inmates for longer periods.

That, Morales says, has increased a kind of recidivist merry-go-round: a growing number of inmates with multiple bookings and short jail stays; people who aren’t getting the treatment they often need.

“I don’t think our script is good yet,” he says. “We don’t explain it well [to inmates], and we have to get better at advocating that someone use medicated-assisted treatment — and to get the protocol right, so that it’s not isolated folks that are doing it.”

Jails need to build the momentum of routine treatment by getting staff and inmates who have been helped talking about the success of this approach, he says. “And frankly, we’re not scaled up enough. Those are the challenges that we’re facing.”

It’s a similar story nationally, where the number of jails offering medication for inmates who are addicted is small.

Only 10% to 12% of the nation’s 4,000 jails are trying some form of addiction medication as part of treatment.

“Although this number is not the majority of jails, five years ago it was zero,” says Klein. “And the number is increasing every week.”

Some are offering access to the opioid substitute drugs buprenorphine and methadone, which can help opioid users detox and then temper cravings. Long term, in theory, those drugs can help people who have become addicted to opioids stay off of destructive and potentially deadly street versions.

But the majority of jail-based medication-assisted treatment programs today are limited to injectable naltrexone, given upon an inmate’s release.

Also known by its brand name Vivitrol, naltrexone is an injectable drug that could trigger withdrawal symptoms in someone who is physically dependent on opioids; but it also blocks the brain’s receptors for opioids and alcohol for 28 days.

Inmates who have been addicted to opioids are at far greater risk for overdose upon release, as their tolerance for street drugs is often greatly reduced after a stint of abstinence. Suddenly, a dose that got them high in the old days could now be fatal.

Liability concerns and the need to improve withdrawal management are also driving the increase in medication-assisted treatment. About 80%

. of all detoxification for drugs and alcohol happen in jails and prisons. And nationally, in the last 10 years, counties and states have paid out well over $70 million for addiction withdrawal-related deaths of inmates, according to a tally by Klein. More than 50 similar lawsuits are still pending.

Klein says the challenge is far broader than jails for a public health system that has yet to catch up to the opioid crisis. “MAT is totally underutilized in the community, much less in jails,” he says.

The problem is particularly hard for jails in more rural and semi-rural counties, which often have limited access to medications, to physicians who will administer it, and to follow-up programs that inmates can tap into upon release.

To provide methadone, for example, a jail has to either be certified as a methadone clinic or partner with a community clinic.

“Even if [rural jails] wanted to provide medication-assisted treatment within the jails, there may not be a methadone clinic for 60 miles,” says Carrie Hill, director of the National Sheriffs’ Association’s center for jail operations. “It’s a huge issue.”

Or a county may not have a doctor with the necessary licenses to provide treatment medications, Hill says.

Most rural areas “don’t have a single doctor who is certified to even prescribe buprenorphine,” says Klein. “So it’s very difficult for a jail to even find a doctor who can prescribe it to an inmate who may need it. Most rural and suburban counties in this country don’t have any methadone clinics they can rely on.”

Hill says the sheriffs in her group are working on ways to expand treatment and recovery support services to rural areas, including city-rural treatment partnerships; additional funding to greatly expand telemedicine and broadband services; and mobile anti-opioid addiction units that could deliver treatment drugs to hard-to-reach jails.

The group is in conversation with its federal partners to get the necessary medical waivers to do that.

Advocates for expanding MAT say the medications are saving lives. “In jail, [when] we have somebody stabilized — off street drugs — they can begin to calm down and [we can] find out if we can help them with medication,” Klein says. “What a tragedy if we miss that moment.”

The legislature in Massachusetts, with Koutoujian’s encouragement, has given the green light for a seven-county pilot program of the best evidence-based opioid treatment in jails. Starting this August, the jails will offer all forms of medication-assisted treatment and carefully track data on efficacy — including rates of drug relapse, overdose and recidivism.

While he supports MAT in general, Koutoujian, the sheriff, says he’s wary that medications alone will solve the inmate addiction treatment problem. That kind of thinking, he says, got us into this crisis in the first place.

“Medication-assisted treatment is very important but people have to remember if you do the medication without the treatment portion — the counseling and the supports — it will fail. And we will just fall prey to another easy solution that just simply does not work.”

“We have to make sure, if we are going to use medication-assisted treatment,” Koutoujian says, “that when they leave our facility they will have access to medication. Do they have health insurance to cover that medication? Do they have access to counseling and treatment services and navigators to help them through this most difficult time period? If they don’t have that, then in many ways we could be setting them up for greater failure.”

Meanwhile, in San Mateo’s jail, inmate Felipe Chavez says he wants to serve his time, reconnect with an infant daughter he barely knows and try “to live a different life.”

“I mean, I know everyone says that while they’re in here,” Chavez says. “But, you know, I’m really trying to just get my family back together. Change the way of life.”

To do that, Chavez says, for now he wants to stay in the jail’s fledgling medication-assisted treatment program — to help him stay off fentanyl and stay alive.

Let’s block ads! (Why?)


No Image

Rochester Drug Cooperative Faces Federal Criminal Charges Over Role In Opioid Epidemic

NPR’s Audie Cornish talks with Gary Craig, a Democrat and Chronicle reporter, about the first major pharmaceutical distributor to face federal criminal charges over its role in the opioid epidemic.



AUDIE CORNISH, HOST:

Today Rochester Drug Cooperative became the first pharmaceutical distributer to face federal criminal charges for its role in the opioid epidemic. RDC is charged with conspiring to distribute drugs and defrauding the federal government. The charges are a result of a two-year investigation that began after it was found that RDC ignored pill limits for pharmacies and catered to doctors who over-prescribe.

Gary Craig is an investigative reporter with the Democrat and Chronicle newspaper in Rochester, N.Y. Welcome to the program.

GARY CRAIG: Thanks for having me.

CORNISH: Give us some background on the lawsuit that led to the two-year investigation. What were the red flags for the Drug Enforcement Administration?

CRAIG: Well, it – you know, it appears the criminal and civil investigation began back in 2017. And you know, what they discovered according to court papers – and RDC has pretty much admitted to this – is that clear warning signs from the pharmacies that RDC distributes to – clear warning signs that they were just sort of excessively pushing out opioids were ignored by RDC or, even when highlighted internally by compliance officers, were not brought to the attention of DEA as required.

CORNISH: What does that mean? What kind of signals are we talking about?

CRAIG: There’s a number of them that the federal prosecutors mentioned, things like excessive purchases with cash in some pharmacies, purchases from well out of the region of the pharmacies. And these are opioid purchases we’re talking about – excessively high percentages of sales of fentanyl patches and opioid oxycodone painkillers from some pharmacies and some of the larger pharmacies that RDC dealt with. So those are some of the things that the feds highlighted.

CORNISH: Two RDC executives face charges. What are they accused of?

CRAIG: Basically sort of being players in this whole, you know, alleged kind of ignorance or willing ignorance, I should say, of RDC’s role in the opioid epidemic, the things we talked about – you know, just sort of closing your eyes to pharmacies that were obviously pushing painkilling prescription meds onto the streets in big numbers. And the allegations are that the former CEO, Larry Doud, and former compliance officer were key in allowing this to happen internally and just ignored all the signs. One has pleaded guilty and is cooperating. And Doud is facing the criminal charges.

CORNISH: You’ve talked a lot about the pharmacies here. And so I’m wondering, what about them? And what about the doctors making the orders? Are they being held accountable?

CRAIG: Well, it’s an interesting relationship. The Rochester Drug Cooperative, as the name obviously implies, is a cooperative. Its very members – sort of voting members, et cetera – are the 1,300 pharmacies to which it distributes medications. So the New York attorney general last month filed lawsuits against a number of pharmaceutical manufacturers and RDC as well, claiming that this sort of breeds almost an incestuous relationship where when your very members or the people who are your entity itself are the ones that are selling the pharmaceuticals, you have less of a willingness to basically do the right thing.

CORNISH: Is this a sign of things to come? I mean, is this setting an important precedent in terms of this being criminal charges?

CRAIG: I would think so. You know, as they clearly highlighted at the news conference today – the federal authorities in Manhattan – that this is the first of its kind. And obviously they’ve turned a corner with law enforcement as far as making this decision that instead of solely pursuing these things civilly, they’re going to now pursue criminally. So I would assume that we would see other federal prosecutions of a similar nature.

CORNISH: Gary Craig is an investigative reporter with the Democrat and Chronicle newspaper. Thanks so much.

CRAIG: Thank you.

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)


No Image

Google Searches For Ways To Put Artificial Intelligence To Use In Health Care

Google is looking to artificial intelligence as a way to make a mark in health care.

Michael Short/Bloomberg via Getty Images


hide caption

toggle caption

Michael Short/Bloomberg via Getty Images

One of the biggest corporations on the planet is taking a serious interest in the intersection of artificial intelligence and health.

Google and its sister companies, parts of the holding company Alphabet, are making a huge investment in the field, with potentially big implications for everyone who interacts with Google — which is more than a billion of us.

The push into AI and health is a natural evolution for a company that has developed algorithms that reach deep into our lives through the Web.

“The fundamental underlying technologies of machine learning and artificial intelligence are applicable to all manner of tasks,” says Greg Corrado, a neuroscientist at Google. That’s true, he says, “whether those are tasks in your daily life, like getting directions or sorting through email, or the kinds of tasks that doctors, nurses, clinicians and patients face every day.”

Corrado knows a bit about that. He helped Google develop the algorithm that Gmail uses to suggest replies.

The company also knows the value of being in the health care sphere. “It’s pretty hard to ignore a market that represents about 20 percent of [U.S.] GDP,” says John Moore, an industry analyst at Chilmark Research. “So whether it’s Google or it’s Microsoft or it’s IBM or it’s Apple, everyone is taking a look at what they can do in the health care space.”

Google, which provides financial support to NPR, made a false start into this field a decade ago. The company backed off after a venture called Google Health failed to take root. But now, Google has rebooted its efforts.

Hundreds of employees are working on these health projects, often partnering with other companies and academics. Google doesn’t disclose the size of its investment, but Moore says it’s likely in the billions of dollars.

One of the prime movers is a sister company called Verily, which this year got a billion-dollar boost for its already considerable efforts. Among its projects is software that can diagnose a common cause of blindness called diabetic retinopathy and that is currently in use in India. Verily is also working on tools to monitor blood sugar in people with diabetes, as well as surgical robots that learn from each operation.

“In each of these cases, you can use new technologies and new tools to solve a problem that’s right in front of you,” says cardiologist Jessica Mega, Verily’s chief medical and scientific officer. “In the case of surgical robotics, this idea of learning from one surgery to another becomes really important, because we should be constantly getting better.”

Mega says the rise of artificial intelligence isn’t that big a departure from devices we’re used to, like pacemakers and implantable defibrillators, which jump into action in response to health signals from the body. “So patients are already seeing this intersection between technology and health care,” she says. “It’s just we’re hitting an inflection point.”

That’s because the same kinds of algorithms that are giving rise to self-driving cars can also operate in the health care sphere. It’s all about managing huge amounts of data.

Hospitals have gigabytes of information about the typical patient in the form of electronic health records, scans and sometimes digitized pathology slides. That’s fodder for algorithms to ingest and crunch. And Mega says there’s a potential to wring a lot more useful information out of it.

“There’s this idea that you are healthy until you become sick,” she says, “but there’s really a continuum” between health and disease. If computer algorithms can pick up early signs of a slide toward disease, that could help people avoid getting sick.

But medical data aren’t typically collected for research purposes, so there are gaps. To close those, Verily has partnered with Duke University and Stanford University in an effort called Project Baseline, which seeks to recruit 10,000 volunteers to give tons more data to the company.

Judith Washburn and her husband, James Davis, have volunteered to be subjects in Project Baseline, an effort to gather a range of detailed data to characterize and predict how people move from health to illness.

Courtesy of James Davis


hide caption

toggle caption

Courtesy of James Davis

Judith Washburn, a 73-year-old medical librarian and resident of Palo Alto, Calif., signed up after she saw a recruiting ad. “A couple months later, I got a call to go in, and it’s two days of testing, two different weeks and it’s very thorough,” she says.

She had heart scans, blood tests, skin swabs and stress tests — a checkup on steroids, if you pardon the expression. Her husband, James Davis, decided he’d give it a go as well.

“They were having trouble finding African-American participants at the time, so I was pretty much a shoo-in,” he says. “I’m aware of people who donate their bodies to medical science when they die,” he says, “so it’s sort of a way of donating your body while it’s still alive.”

The retired aerospace engineer also got an added benefit. The doctors diagnosed a serious heart condition, and Davis then had triple bypass surgery to treat it.

The couple replies to quarterly questionnaires, a gizmo under their mattress tracks their sleep patterns and they each wear a watch that monitors their hearts. The watches also count their steps — sort of.

“They haven’t quite figured out your exercise yet,” Washburn says. “In fact, I can knit and get steps!”

All this highly personal information goes into the database of a private corporation. Both Washburn and Davis thought about that before signing up but ultimately concluded that’s OK.

“It depends upon what they’re using it for,” Washburn says. “And if it’s all for research, I’m fine with that.”

Here’s what makes Google’s position unique. Some of the most useful data could be what the company collects while you’re running a Google search, using Gmail or using its Chrome browser.

“As companies like Google and other traditional consumer-oriented companies start moving into this space, it is certainly clear that they bring the capability of taking much of the information they have about us and be able to apply it,” says Reed Tuckson, a well-known academic physician who was recently recruited to advise Verily about Project Baseline.

For example, people’s browsing history can reveal a lot about what they buy, how they exercise and other facets of their lifestyles.

“We now understand that that has a great deal to do with the health decisions that we make,” says Tuckson, who is on a National Academy of Medicine working group that’s exploring artificial intelligence in medicine.

He says Google needs to tread carefully around these privacy issues, but he’s bullish on the technology.

“We should remember that the status quo is not acceptable by itself and that we’ve got to use every tool at our disposal — use them intelligently” to improve the health of Americans, he says. “And I think that’s why it’s exciting.”

Tuckson isn’t the only influential recruit to the effort. Verily recently brought in Dr. Robert Califf, a former Food and Drug Administration commissioner, as well as Vivian Lee, a radiologist who headed the University of Utah’s health care system. Google hired David Feinberg, a physician who ran Geisinger, a major health care provider based in Danville, Pa.

“It seems like it was a bit of a war on talent right now between Amazon and Google and to a certain extent Apple,” says Moore, the analyst. Google needs to build credibility in the medical sphere.

“I think Google is trying to have those people that can basically proof out what Google is doing and stand up and say, ‘Yes, Google can do this,’ ” Moore says.

He also has his eye on what the company’s investment means for the rapidly developing industry around health care and artificial intelligence. “Anyone should take Google very seriously,” he says.

Some big players, like Apple and Microsoft, can hold their own.

“For other AI companies that don’t have those resources, they’re going to have to be very judicious in picking the niches they want to target, niches that are ones that, frankly, Google is not terribly interested in,” Moore says.

Getting the technology to work is just the start.

The health care business is “a very complex ecosystem,” says Dr. Lonny Reisman, a former health insurance executive who now heads HealthReveal, a company that develops algorithms to help doctors choose the appropriate therapy. Google will need to answer many questions as it enters that landscape.

Who will have an incentive to buy software based on artificial intelligence? Will it really save time or money, as advocates often assert? Or is it just the next new driver of health care inflation?

“There are all these competing forces around cost containment,” Reisman says. It’s not easy to balance innovation, access, fairness and health equity, he adds, “so they’ve got a lot on their plate.”

Google’s Corrado says collaborations with academics and the health care industry are key for navigating this territory.

“A big part of the way that research and development should work in this space is by having kind of a long-term portfolio of technologies that you percolate through the academic and scientific community and then you percolate through the clinical community,” Corrado says.

For all the challenges of forging a new path into health care, Google has a potentially enormous advantage in all the data it collects from its billions of users.

Corrado says the company is well aware of the sensitivity of putting that information to use and is thinking about how to approach that without provoking a backlash.

“It has to be something that is driven by the patients’ desire to use their own information to better their wellness,” Corrado says.

In a world where people are increasingly concerned about how their personal data are exploited, that could be even more of a challenge than building the computer algorithms to digest and interpret it all.

You can contact NPR science correspondent Richard Harris at rharris@npr.org.

Let’s block ads! (Why?)


No Image

Amid Rural Doctor Shortage, Dozens Of Medical Workers Charged In Opioid Crackdown

A recent opioid sting caught 60 people, including doctors, accused of enabling addicts. Physician Stephen Loyd tells NPR’s Sacha Pfeiffer how the sting could affect addicted patients.



SACHA PFEIFFER, HOST:

A crackdown this week on opioid abuse resulted in federal criminal charges against 60 people accused of illegally prescribing and distributing opioids. They include doctors, nurses and pharmacists. One even allegedly traded drugs for sex. That sting focused on Appalachia, one of the areas hardest hit by the opioid epidemic. It’s a mostly rural area where access to health care is already a challenge for residents.

So we wanted to know about the impact of this crackdown on both addicts and people who rely on opioids to manage chronic pain. That’s something Dr. Stephen Loyd has been thinking a lot about over the last few days. He’s based in Nashville. And he’s the state of Tennessee’s former assistant commissioner for substance abuse. He’s also a former addict, and now works with addiction recovery programs in the Nashville area. Dr. Loyd, thank you for talking with us about this.

STEPHEN LOYD: Thanks so much for having me, Sacha.

PFEIFFER: More than half the people charged in the sting are from Tennessee, where you live. Seventeen of them are doctors. Give us some perspective on what happens when you remove 17 doctors and other health care officials from a rural area that already has a doctor shortage even if those doctors were doing criminal things?

LOYD: That’s something that, you know, that I think we really need to consider because a lot of these areas have a hard time recruiting providers in the first place. And I ran into this in previous work that I had done against doctors and nurse practitioners who were improperly prescribing. And even in open-and-shut cases, it’s very hard to remove those doctors from the community in front of the jury of their peers because they’re the only health care sometimes, you know, for miles.

And so it is an impact on the community. And I think that a lot of consideration has been given to that by our state officials. But it is an impact because of the restricted access to care, even if they are bad providers when it comes to prescribing controlled substances.

PFEIFFER: Well, and the reality is that some of these health care professionals who were charged will probably not be able to practice again. That really impacts people who relied on them to get opioids to manage chronic pain. What are the options for those patients now?

LOYD: There’s only so much you can do, Sacha, right? You can direct them towards another health care provider. But a lot of times, we’re talking about, you know, certified legitimate pain medicine doctors – which I can tell you, there are not enough of in our state, and certainly aren’t enough of in rural Appalachia – and then those people with addiction, you know, the people who, you know, who have been feeding their addiction through these illicit prescriptions. Legitimate addiction medicine doctors that are going to utilize evidence based practice, there is a shortage of those as well.

Now, if we’re talking about state agencies and state funded agencies that, you know, such things as the 21st Century Cures Act money that came down a few years ago initiated by President Obama and then, you know, followed through on with President Trump, that’s really good access to care. And my state’s done a great job with that. But the problem lies outside of their control, right? Because now we’re really talking about the stigma associated with chronic pain patients as well as patients with addiction disease, and therein is the underlying problem.

PFEIFFER: In terms of how to help people who’ve lost their doctors in this sting, the Tennessee Department of Mental Health and Substance Abuse Services has publicized two hotlines that people can call to find treatment services or counselling. And they say they’re offering more training sessions to teach people how to use naloxone, the overdose reversal drug. Do you think that’s enough outreach?

LOYD: I think it’s a great response, right? It’s a great initial response. But I want you to think of it from a patient standpoint, and that’s where I come from. So – because I work in this everyday and I see the mindset – so it takes a lot to pick up the phone and call a hotline. And then, you know, being directed from care there, there’s a lot of follow through that has to happen. And there’s some folks that won’t do that for a lot of reasons. And so a lot of times, the easier alternative is is to seek it illicitly. So is it enough? No, I don’t think it’s ever enough. But I don’t think it’s anything that state agencies can control right now.

PFEIFFER: So if, as you say, this crackdown could result in people just looking elsewhere for drugs, maybe illegal drugs, what has been accomplished?

LOYD: Well, you have to take players like this out of the business. This is one of the things that frustrates me right now. The pharmaceutical industry points to now is, OK, we’re not talking about prescription pills anymore, right? We’re talking about illicit heroin and fentanyl. But people got started seeking heroin and fentanyl from the prescribing of those pain medications coming out of clinics like this. You absolutely have to cut that off.

The response will be what – where the key is in how we direct people to help.

PFEIFFER: So crack down on the doctors, but make sure there’s a support system ready for their patients.

LOYD: Absolutely. And the thing is – and this is so beautiful – is that when you get to watch lives change. For myself, you know, I used to get up every single morning thinking, you know, where am I going to get my pills? And that occupied my entire day. Now, keep in mind, I was a practicing physician. So I had some other things to do. And that’s what people who are, you know, who are addicted are facing every single day.

And now, you know, providing them with quality help and watching them change their lives is one of the most fun things that I’ve ever been involved with. We need to make that opportunity more widespread. We need to decrease the stigma around stepping out and ask for help. And also, Sacha, we need to make evidence-based treatment available without the stigma that goes along with it.

PFEIFFER: That’s Dr. Steven Loyd. He’s based in Nashville, Tenn. Thanks for talking with us.

LOYD: Thank you.

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)


No Image

‘This Is Morally Wrong’: Biden Supports Striking Massachusetts Grocery Workers

Union members picket a Stop & Shop in Dorchester, Mass., prior to the arrival of former Vice President Joe Biden on Thursday.

Scott Eisen/Getty Images


hide caption

toggle caption

Scott Eisen/Getty Images

Former Vice President Joe Biden told a rally in Dorchester, Mass., Thursday that the 31,000 Stop & Shop workers on strike in New England are part of a movement to “take back this country.”

“I know you’re used to hearing political speeches, and I’m a politician. I get it,” said Biden, who is mulling over a White House bid in 2020. “But this is way beyond that, guys. This is way beyond that. This is wrong. This is morally wrong, what’s going on around this country. And I have had enough of it. I’m sick of it, and so are you.”

Biden, a Democrat, was quick to support members of the United Food & Commercial Workers union when they walked off the job last week.

In the last 5 years, @StopandShop‘s parent company has bought back billions of dollars in stock. Now they want to cut employee wages & benefits. This is wrong. I stand with the 31,000 @UFCW workers fighting for their healthcare. Join me and support them: https://t.co/D4baO7D5xH

— Joe Biden (@JoeBiden) April 12, 2019

Thursday’s appearance in Boston gave Biden face time with a key Democratic constituency — blue-state union members — on the home turf of potential primary rival Sen. Elizabeth Warren, who already has entered the presidential race.

“Probably it’s more benefiting him than us,” said Peter Amati, a longtime florist at the Stop & Shop in Milford, Mass. “This is the right place.”

Warren joined picketing Stop & Shop workers in Somerville, Mass., last Friday, saying, “Unions built America’s middle class, and unions will rebuild America’s middle class.”

Biden’s message was similar, though he delivered it without the Dunkin’ doughnuts that Warren brought along.

Stop & Shop workers went on strike to protest the company’s proposed changes to wages and benefits. Labor contracts for five UFCW chapters in Massachusetts, Connecticut and Rhode Island expired Feb. 23, and the two sides have been unable to agree to new terms despite meeting with a federal mediator.

Stop & Shop, a subsidiary of the Dutch conglomerate Ahold Delhaize, is asking workers to contribute more to their health insurance premiums. The company says workers currently pay an average of 8.2% of the cost of single coverage and 6.6% of the cost of family coverage. Those contributions are well below national averages, according to the Kaiser Family Foundation’s 2018 Employer Health Benefit Survey.

Stop & Shop also wants to reduce pensions for some workers, arguing that the company is an industry outlier and therefore at a competitive disadvantage. Stop & Shop wants to freeze its monthly pension-fund contribution for new full-time workers. Pension payments for part-time workers hired after Feb. 23, 2014, would stop increasing under the company’s proposal.

In addition, Stop & Shop wants to freeze the 50% hourly bonus paid to part-time workers on Sundays. New part-time hires would receive smaller bonuses: an extra $1 per hour for the first year of employment and $2 per hour after that.

The eight-day strike has shuttered some Stop & Shop stores and slowed business at others, as the company offers reduced hours and limited food selections.

Picketers are going without pay and say they don’t expect much financial assistance from the union. Paul Batista, a butcher at the Stop & Shop on Everett Street in Allston, Mass., told WBUR this week that the union won’t begin to make up for lost wages until the strike hits the two-week mark, and checks will be just $100 per week for full-time workers and $50 per week for part-timers.

Batista added that May 1 is an important date for striking Stop & Shop workers: That’s when company-sponsored health insurance will lapse, he said.

Strikers can apply for unemployment benefits but might not receive them. According to the Massachusetts Executive Office of Labor and Workforce Development, “employees participating in a labor dispute (i.e., strike) that results in a substantial curtailment of the employer’s business do not qualify for benefits.”

Let’s block ads! (Why?)


No Image

How Well Do Workplace Wellness Programs Work?

A large new study finds mixed results for the effectiveness of programs aimed at motivating healthful behavior — such as more exercise and better nutrition — among employees.

Erik Isakson/Getty Images/Tetra images RF


hide caption

toggle caption

Erik Isakson/Getty Images/Tetra images RF

Workplace wellness programs — efforts to get workers to lose weight, eat better, stress less and sleep more — are an $8 billion industry in the U.S.

Most large employers offer some type of wellness program, with growth fueled by incentives in the federal Affordable Care Act.

But no one has been sure they work. Various studies over the years have provided conflicting results, with some showing savings and health improvements while others say the efforts fall short.

Many studies, however, faced a number of limitations, such as failing to have a comparison group, or figuring out whether people who sign up for such wellness programs are somehow healthier or more motivated than those who do not.

Researchers from the University of Chicago and Harvard may have overcome some of these obstacles with one of the first large-scale studies to be peer-reviewed and employ a randomized controlled trial design. They published their findings Tuesday in the medical journal JAMA.

The scientists randomly assigned 20 BJ’s Wholesale Club outlets to offer a wellness program to all employees, then compared results with 140 stores that did not.

The big-box retailer employed nearly 33,000 workers across all 160 clubs during the test.

The wellness program consisted of asking participating workers to fill out a health risk questionnaire, have some medical tests, such as blood pressure and blood glucose, and take up to eight classes on topics such as nutrition and exercise.

After 18 months, it turned out that, yes, workers participating in the wellness programs self-reported healthier behavior than those not enrolled, such as exercising more or managing their weight better.

But the efforts did not result in differences in health measures, such as improved blood sugar or glucose levels, how much employers spent on health care or how often employees missed work. Their job performance and how long they stuck around in their jobs also seemed unaffected, the researchers say.

“The optimistic interpretation is there is no way we can get improvements in health or more efficient spending if we don’t first have changes in health behavior,” says Katherine Baicker, dean of the Harris School of Public Policy at the University of Chicago, and one of the study’s authors. (Dr. Zirui Song, an assistant professor of health policy and medicine at Harvard Medical School, was its co-author.)

“But if employers are offering these programs in hopes that health spending and absenteeism will go down, this study should give them pause,” Baicker says.

The study comes amid widespread interest in wellness programs.

The Kaiser Family Foundation’s annual survey of employers found that 53 percent of small firms and 82 percent of large firms offer a program in at least one of these areas: smoking cessation, weight management, and behavioral or lifestyle change. (Kaiser Health News is an editorially independent program of the foundation.)

Some programs are simple, offering gift cards or other small incentives to fill out a health risk assessment; take a lunch-and-learn class; or join a gym or walking group. Others are far more invasive, asking employees to report on a variety of health-related questions and roll up their sleeves for blood tests.

A few employers offer financial incentives to workers who actually reduce their risk factors — lowering high blood pressure, for example, or reducing levels of bad cholesterol — or who make concerted efforts to participate in programs that might help them reduce these risk factors over time.

The Affordable Care Act allowed employers to offer financial incentives worth up to 30 percent of the cost of health insurance — that led some employers to entice workers with what could amount to hundreds or even thousands of dollars in discounted insurance premiums or reduced deductibles.

Such large financial incentives led to court challenges about whether those programs are truly voluntary. The result of such cases is still unclear — a judge has asked the Equal Employment Opportunity Commission to revise the rules governing the programs, but those revisions are not expected to be published this year.

In the study reported in JAMA, the incentives were modest. Participants got small-dollar gift cards for taking wellness courses on topics such as nutrition, exercise, disease management and stress control. Total potential incentives averaged $250. About 35 percent of eligible employees at the 20 participating sites completed at least one module.

Results from those workers — including attendance and tenure data, their self-reported health assessment and results from lab blood tests — were specifically compared with similar reports from 20 primary comparison sites where workers were not offered the wellness gift cards and classes. Overall employment and health spending data from all worksites were included in the study.

Wellness program vendors say details matter when considering whether efforts will be successful.

Jim Pshock, founder and CEO of Bravo Wellness, says the incentives offered to BJ’s workers might not have been large enough to spur the kinds of big changes needed to affect health outcomes.

Amounts “of less than $400 generally incentivize things people were going to do anyway,” Pshock says. “It’s simply too small to get them to do things they weren’t already excited about.”

An accompanying editorial in JAMA notes that “traditional, broad-based programs like the one analyzed by Song and Baicker may lack the necessary intensity, duration, and focus on particular employee segments to generate significant effects over a short time horizon.”

In other words, don’t give up entirely on wellness efforts, but consider “more targeted approaches” that focus on specific workers who have higher risks, or on “health behaviors [that] may yield larger health and economic benefits,” the editorial suggests.

It could be, the study acknowledges, that 18 months isn’t enough time to track such savings. So, Baicker and Song also plan to publish three-year results once they are finalized.

Still, similar findings were recently reported by the University of Illinois, where individuals were randomly selected to be offered wellness programs. This study, published in 2018 by the National Bureau of Economic Research, concluded that the workplace wellness program did not reduce health care costs or change health behaviors.

In one interesting point, that study found that wellness-program participants were likely already healthier and more motivated, “thus a primary benefit of these programs to employers may be their potential to attract and retain healthy workers with low medical spending,” the authors write.

Everyone involved in studying or conducting wellness agrees on one thing: Changing behavior, and getting people motivated to participate at all, can be difficult.

Steven Aldana, CEO of WellSteps, a wellness program vendor, says that for the efforts to be successful, they must cut across many areas — from the food served in company cafeterias to including spouses or significant others in helping people quit smoking, eat better or exercise more.

“Behavior is more complicated than simply taking a few wellness modules,” Aldana said. “It’s a lifestyle matrix or pattern you have to adopt.”


Kaiser Health News is an editorially independent, nonprofit program of the Kaiser Family Foundation. KHN is not affiliated with Kaiser Permanente.

Let’s block ads! (Why?)